Lmr Partners LLP Summit Therapeutics Inc. Put Options Transaction History

Lmr Partners LLP

  • $8.3 Billion
  • Q1 2025

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2025

May 15, 2025
BUY
$16.65 - $23.76 $249,749 - $356,400
15,000 Added 12.32%
136,800 $2.64 Million
Q4 2024

Feb 14, 2025
BUY
$17.52 - $23.46 $381,936 - $511,428
21,800 Added 21.8%
121,800 $2.17 Million
Q3 2024

Nov 07, 2024
BUY
$6.89 - $31.93 $344,500 - $1.6 Million
50,000 Added 100.0%
100,000 $2.19 Million
Q2 2024

Aug 14, 2024
BUY
$2.39 - $10.92 $119,500 - $546,000
50,000 New
50,000 $390,000

Others Institutions Holding SMMT

# of Institutions
246
Shares Held
87.4M
Call Options Held
1.77M
Put Options Held
2.48M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $6.04B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email